EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage

Harikrishnan Balachandran, Kyle Kroll, Karen Terry, Cordelia Manickam, Rhianna Jones, Griffin Woolley, Tammy Hayes, Amanda J Martinot, Ankur Sharma, Mark Lewis, Stephanie Jost, R Keith Reeves iD

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Harikrishnan Balachandran und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Innate and Comparative Immunology, Center for Human Systems Immunology, Duke University School of Medicine, Durham, North Carolina, Unite…. Hauptthemen laut MEDLINE: Killer Cells, Natural, SARS-CoV-2, COVID-19, Virus Replication. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells play a critical role in virus control. However, it has remained largely unclear whether NK cell mobilization in SARS-CoV-2 infections is beneficial or pathologic. To address this deficit, we employed a validated experimental NK cell depletion non-human primate (NHP) model with SARS-CoV-2 Delta variant B.1.617.2 challenge. Viral loads (VL), NK cell numbers, activation, proliferation, and functional measures were evaluated in blood and tissues. In non-depleted (control) animals, infection rapidly induced NK cell expansion, activation, and increased tissue trafficking associated with VL. Strikingly, we report that experimental NK cell depletion leads to higher VL, longer duration of viral shedding, significantly increased levels of pro-inflammatory cytokines in the lungs, and overt lung damage. Overall, we find the first significant and conclusive evidence for NK cell-mediated control of SARS-CoV-2 virus replication and disease pathology. These data indicate that adjunct therapies for infection could largely benefit from NK cell-targeted approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalSARS-CoV-2COVID-19Virus ReplicationLungViral LoadAnimalsDisease Models, AnimalMacaca mulattaPandemicsHumans

Autor:innen und Institutionen

  • Division of Innate and Comparative Immunology, Center for Human Systems Immunology, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Department of Infectious Diseases and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, United States of America.
  • BIOQUAL, Inc., Rockville, Maryland, United States of America.
  • Department of Surgery, Duke University School of Medicine, Durham, North Carolina, United States of America.

ORCID-Profile: R Keith Reeves

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • NICHD NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Child Health and Human Development
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Balachandran, H., Kroll, K., Terry, K., Manickam, C., Jones, R., Woolley, G., Hayes, T., Martinot, A. J., Sharma, A., Lewis, M., Jost, S., & Reeves, R. K. (2024). NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012439

Vancouver

Balachandran H, Kroll K, Terry K, Manickam C, Jones R, Woolley G, et al. NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012439

BibTeX
@article{Balachandran2024,
  author = {Balachandran, Harikrishnan and Kroll, Kyle and Terry, Karen and Manickam, Cordelia and Jones, Rhianna and Woolley, Griffin and Hayes, Tammy and Martinot, Amanda J and Sharma, Ankur and Lewis, Mark and Jost, Stephanie and Reeves, R Keith},
  title = {NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012439}
}
Kostenlos starten →